GLYCOGEN STORAGE DISEASE TYPE II

GLYCOGEN STORAGE DISEASE TYPE II was reported 105 times

These drug classes are most commonly taken by patients reporting GLYCOGEN STORAGE DISEASE TYPE II:

# Drug Count
0 Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] 27
1 Folate Analog Metabolic Inhibitor [EPC] 12
2 Catecholamine [EPC] 6
3 HMG-CoA Reductase Inhibitor [EPC] 6
4 alpha-Adrenergic Agonist [EPC] 6
5 beta-Adrenergic Agonist [EPC] 6
6 Nonsteroidal Anti-inflammatory Drug [EPC] 5
7 Osmotic Laxative [EPC] 5
8 CD20-directed Cytolytic Antibody [EPC] 4
9 Corticosteroid [EPC] 4
10 Loop Diuretic [EPC] 4
11 Histamine-1 Receptor Antagonist [EPC] 2
12 Histamine-2 Receptor Antagonist [EPC] 2
13 Aminoglycoside Antibacterial [EPC] 1
14 Angiotensin 2 Receptor Blocker [EPC] 1
15 Anti-epileptic Agent [EPC] 1
16 Antimalarial [EPC] 1
17 Antiprotozoal [EPC] 1
18 Atypical Antipsychotic [EPC] 1
19 Benzodiazepine [EPC] 1
20 Calcineurin Inhibitor Immunosuppressant [EPC] 1
21 Calcium Channel Blocker [EPC] 1
22 Dihydropyridine Calcium Channel Blocker [EPC] 1
23 GLP-1 Receptor Agonist [EPC] 1
24 General Anesthetic [EPC] 1
25 Glycopeptide Antibacterial [EPC] 1
26 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
27 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
28 Human Immunoglobulin G [EPC] 1
29 Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] 1
30 Interleukin-12 Antagonist [EPC] 1
31 Interleukin-23 Antagonist [EPC] 1
32 Janus Kinase Inhibitor [EPC] 1
33 Parathyroid Hormone Analog [EPC] 1
34 Phosphodiesterase 5 Inhibitor [EPC] 1
35 Platinum-based Drug [EPC] 1
36 Serotonin-3 Receptor Antagonist [EPC] 1
37 Tumor Necrosis Factor Blocker [EPC] 1